Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-25-000102 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
27.47% · OPTIONAL · VALID
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.30% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.58% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
8.99% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
48.19% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
23.14% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.93% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 40.51%
Current 27.47%
Delta -13.04% Capex Intensity Increased
Previous 2.77%
Current 3.30%
Delta 0.53% Cash Generation Decreased
Previous 19.78%
Current 13.58%
Delta -6.20% Growth Decreased
Previous 9.38%
Current 8.99%
Delta -0.39% Inventory Pressure Decreased
Previous 52.78%
Current 48.19%
Delta -4.58% Margin Increased
Previous 20.46%
Current 23.14%
Delta 2.67% Profitability Increased
Previous 12.45%
Current 15.93%
Delta 3.48% R And D Intensity Decreased
Previous 0.86%
Current 0.56%
Delta -0.30% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.